105 related articles for article (PubMed ID: 4463505)
1. [Effect of ionic strength on the anticholinesterase properties of some new organophosphorus compounds].
Krasheniuk AI; Mikhaĭlov SS; Rozengart VI; Abduvakhabov AA
Ukr Biokhim Zh; 1974; 46(5):586-90. PubMed ID: 4463505
[No Abstract] [Full Text] [Related]
2. [Synthesis and anticholinesterase activity of acetylene organophosphorus compounds].
Balashova EK; Brestkin AP; Zhukovskiĭ IuG; Rozengart VI; Sherstobitov OE
Dokl Akad Nauk SSSR; 1983; 272(2):503-6. PubMed ID: 6679836
[No Abstract] [Full Text] [Related]
3. [Catalytic properties and sensitivity to various inhibitors of the cholinesterase from the salivary glands of the mollusc Murex trunculus (Gastropoda)].
Grigor'eva GM
Biokhimiia; 1973; 38(6):1126-36. PubMed ID: 4801968
[No Abstract] [Full Text] [Related]
4. [Anticholinesterase effect of potential organophosphorus synergists of pyrethroids].
Khrunin AV; Eremina OIu
Gig Sanit; 2000; (3):66-70. PubMed ID: 10900804
[No Abstract] [Full Text] [Related]
5. [Evaluation of the anticholinesterase activity of triethylphosphate in vitro].
Komlev IV; Kuvshinova NN
Gig Tr Prof Zabol; 1979 Nov; (11):54-5. PubMed ID: 527864
[No Abstract] [Full Text] [Related]
6. [The generalized mechanism of the irreversible inhibition of cholinesterase activity by organophosphorus inhibitors].
Agabekian RS; Liubimov VS
Dokl Akad Nauk SSSR; 1991; 318(2):459-66. PubMed ID: 1893839
[No Abstract] [Full Text] [Related]
7. [Pharmacological properties of a series of phosphoric chloralkyl esters].
Timoshenko IaG
Farmakol Toksikol; 1972 Jul; 35(4):494-8. PubMed ID: 5050289
[No Abstract] [Full Text] [Related]
8. Inhibition of butyrylcholinesterase by organophosphorus compounds: a quantitative structure-activity analysis.
Barbato F; Cappello B; Silipo C; Vittoria A
Farmaco Sci; 1982 Aug; 37(8):519-36. PubMed ID: 7128809
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of antichymotryptic and anticholinesterase activity of organophosphorus quasi-substrate inhibitors.
Rozengart EV
Dokl Biochem Biophys; 2008; 419():82-7. PubMed ID: 18505164
[No Abstract] [Full Text] [Related]
10. The relationship between the anticholinesterase effect of organophosphorous inhibitors and the extent of shielding (accessibility) of the phosphorus atom.
Rozengart EV
Dokl Biochem Biophys; 2003; 389():130-3. PubMed ID: 12856422
[No Abstract] [Full Text] [Related]
11. [Structure-activity relationships in acetylcholinesterase reactivators inhibited by organophosphorus compounds. IV. N-hydroxyimidazole-3-oxides and their quaternary salts].
Franchetti P; Grifantini M; Lucarelli C; Stein ML
Farmaco Sci; 1972 Jan; 27(1):46-59. PubMed ID: 4353914
[No Abstract] [Full Text] [Related]
12. [Quaternary phosphonic salts as reversible cholinesterase inhibitors].
Brestkin AP; Brovko VS; Zhukovskiĭ IuG; Kolchanova NA; Rozengart EV
Dokl Akad Nauk SSSR; 1984; 277(3):735-7. PubMed ID: 6489118
[No Abstract] [Full Text] [Related]
13. [Catalytic properties of the acetylcholinesterase from human erythrocytes].
Abramovich TD; Borzunina AM; Golub TL; Eremeeva AM; Zhukovskiĭ IuG
Biokhimiia; 1973; 38(6):1137-43. PubMed ID: 4802004
[No Abstract] [Full Text] [Related]
14. [Study of serum cholinesterase using a spin-labelled inhibitor].
Khodakovskaia OA; Iakovlev VA
Izv Akad Nauk SSSR Biol; 1975; (4):570-9. PubMed ID: 170322
[No Abstract] [Full Text] [Related]
15. [Phosphorus atom availability and mechanism enzyme inhibiting effect of organophosphorous inhibitors of cholinesterases of various origin. Results of conformational and correlational analysis].
Rozengart EV; Shestakova NN; Prokator SO; Basova NE
Zh Evol Biokhim Fiziol; 1999; 35(1):36-9. PubMed ID: 10399821
[No Abstract] [Full Text] [Related]
16. [The use of the multidimensional statistic analysis for investigation of anticholinesterase activity of organophosphorus inhibitors depending on their structure].
Moralev SN; Baziukin AB
Zh Evol Biokhim Fiziol; 1997; 33(3):302-7. PubMed ID: 9479389
[No Abstract] [Full Text] [Related]
17. Irreversible phosphorylation of brain neurotoxic esterase. The primary event leading to the delayed neuropathy caused by some organophosphorus esters.
Johnson MK
Monogr Neural Sci; 1980; 7():99-105. PubMed ID: 7231440
[TBL] [Abstract][Full Text] [Related]
18. [Neuromuscular, anticholinesterase and pressor effects of quaternary ammonium compounds derived from dicresylphosphate].
Cheymol G
Therapie; 1972; 27(3):543-53. PubMed ID: 4655219
[No Abstract] [Full Text] [Related]
19. [Thiohydroximic esters. Rate constants for the reactivation of serum cholinesterase inhibited by GD-42].
Krivenchuk VE; Brizgaĭlo LI; Petrun'kin VE
Biokhimiia; 1974; 39(6):1163-7. PubMed ID: 4461042
[No Abstract] [Full Text] [Related]
20. [Structure-activity relationships in reactivators of acetylcholinesterase inhibited by organophosphoric compounds. 8. Halides of 2- and 4-hydroxy-iminomethyl-1-(omega-(4-imidazolyl)-n-alkyl)pyridinium].
Franchetti P; Grifantini M; Martelli S; Stein ML
Farmaco Sci; 1974 Apr; 29(4):309-16. PubMed ID: 4857121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
